Volume 7.04 | Jan 30

Neural Cell News 7.04 January 30, 2013
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Neural Cell News on Twitter
TOP STORY
Radial Glial Neural Progenitors Regulate Nascent Brain Vascular Network Stabilization via Inhibition of Wnt Signaling
Radial glial neural progenitors are well known for their central role in orchestrating brain neurogenesis. Investigators showed that, in the late embryonic cortex, radial glial neural progenitors also play a key role in brain angiogenesis, by interacting with nascent blood vessels and regulating vessel stabilization via modulation of canonical Wnt signaling. [PLoS Biol] Full Article

Happy Neurons lead to Happy Neuroscientists: NeuroCult SM Primary Neuronal Culture Kits
PUBLICATIONS (Ranked by impact factor of the journal)

Interaction between Autism-Linked MDGAs and Neuroligins Suppresses Inhibitory Synapse Development
Scientists showed that MAM domain-containing glycosylphosphatidylinositol anchor (MDGA)1 and MDGA2 bound to neuroligin-2 inhibitory synapse-organizing protein, also implicated in neurodevelopmental disorders. MDGA1 inhibited the synapse-promoting activity of neuroligin-2, without altering neuroligin-2 surface trafficking, by inhibiting interaction of neuroligin-2 with neurexin. [J Cell Biol] Abstract

S-Nitrosylation of HDAC2 Regulates the Expression of the Chromatin-Remodeling Factor Brm during Radial Neuron Migration
Scientists showed that histone deacetylase 2 (HDAC2) nitrosylation regulates neuronal radial migration during cortical development. Bead-array analysis performed in the developing cortex revealed that brahma (Brm), a subunit of the ATP-dependent chromatin-remodeling complex BRG/brahma-associated factor, is one of the genes regulated by S-nitrosylation of HDAC2. [Proc Natl Acad Sci USA] Abstract

Slitrks Control Excitatory and Inhibitory Synapse Formation with LAR Receptor Protein Tyrosine Phosphatases
Investigators report that Slit- and Trk-like proteins (Slitrks) are enriched in postsynaptic densities in rat brains. Overexpression of Slitrks promoted synapse formation, whereas RNAi-mediated knockdown of Slitrks decreased synapse density. [Proc Natl Acad Sci USA] Abstract

The Potential of Apolipoprotein E4 to Act as a Substrate for Primary Cultures of Hippocampal Neurons
Scientists examined the effect of surface-bound apolipoprotein E4 (apoE4) on developmental features of rat hippocampal neurons. They showed that apoE4 substrates elicit significantly enhanced values in all developmental features at day two of culture when compared to laminin substrates, which is the current substrate-of-choice for neuronal cultures. [Biomaterials]
Abstract | Press Release

A Point Mutation in Semaphorin 4A Associates with Defective Endosomal Sorting and Causes Retinal Degeneration
Researchers generated a series of knock-in mouse lines with corresponding mutations (D345H, F350C or R713Q) in the semaphorin 4A (Sema4A) gene and found that Sema4AF350C causes retinal degeneration phenotypes. The F350C mutation results in abnormal localization of the Sema4A protein, leading to impaired endosomal sorting of molecules indispensable for photoreceptor survival. [Nat Commun] Abstract

Glial Cells Decipher Synaptic Competition at the Mammalian Neuromuscular Junction
Using simultaneous glial Ca2+ imaging and synaptic recordings of dually innervated mouse neuromuscular junctions, researchers report that single glial cells decipher the strength of competing nerve terminals. Activity of single glial cells, revealed by Ca2+ responses, reflects the synaptic strength of each competing nerve terminal and the state of synaptic competition. [J Neurosci] Abstract

MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1
Researchers found that expression of microRNA-195 (miR-195) was markedly downregulated in glioma cell lines and human primary glioma tissues, compared to normal human astrocytes and matched non-tumor associated tissues. [PLoS One] Full Article

Transglial Transmission at the Dorsal Root Ganglion Sandwich Synapse: Glial Cell to Postsynaptic Neuron Communication
Researchers showed that in chick or rat ‘sandwich synapse’ the neuronal somata (NS)-to-satellite glial cell (SGC) leg of the two-synapse pathway is purinergic via P2Y2 receptors but the second SGC-to-NS synapse mechanism remains unknown. [Eur J Neurosci]
Abstract

Temozolomide Suppresses MYC via Activation of TAp63 to Inhibit Progression of Human Glioblastoma
Scientists demonstrated that temozolomide (TMZ) targets TAp63, a p53 family member, inducing its expression to suppress the progression of human glioblastoma multiforme (GBM). High levels of TAp63 expression in GBM tissues after TMZ treatment was an indicator of favourable prognosis. [Sci Rep]
Full Article

Webinar: Brent Reynolds on Identification and Characterization of Neural Stem Cells

REVIEWS
Schizophrenia: A Neurodevelopmental Disorder – Integrative Genomic Hypothesis and Therapeutic Implications from a Transgenic Mouse Model
The authors suggest that altered FGF receptor signaling plays a central role in the developmental abnormalities underlying schizophrenia and that nicotinic agonists are an effective class of compounds for the treatment of schizophrenia. [Schizophr Res] Abstract
INDUSTRY NEWS

Professor Robert W. Williams, PhD, at The University of Tennessee Health Science Center Selected by European Commission to Participate in Human Brain Project
The European Commission has officially announced the selection of the Human Brain Project as one of its two Future & Emerging Technologies Flagship projects. The new project will federate European efforts to address one of the greatest challenges of modern science: understanding the human brain. [University of Tennessee Health Science Center] Press Release

FDA Approves Genzyme’s AUBAGIO® (Teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis
Genzyme, a Sanofi company, announced that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO® as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS). AUBAGIO has shown significant efficacy across key measures of MS disease activity, including reducing relapses, slowing the progression of physical disability, and reducing the number of brain lesions as detected by MRI. [Genzyme Corporation, a Sanofi Company] Press Release

POLICY NEWS

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

EVENTS
NEW Center for iPS Cell Research and Application (CiRA) International Symposium 2013 – Raising the Next Generation of Stem Cell Research
March 11, 2013
Kyoto, Japan

Visit our events page to see a complete list of events in the neural cell community.
JOB OPPORTUNITIES

Postdoctoral Position – Neurobiology (Weizmann Institute of Science)

Postdoctoral Position(s) – Cell Biology, Biophysics and Neurobiology (University of Missouri, Kansas City)

Postdoctoral Position – Systems Biology, Neurodegenerative Diseases (The Microsoft Research-University of Trento [COSBI])

Postdoctoral Position – Neural Stem Cells and Neurodevelopment (University of Wisconsin – Madison)

Postdoctoral Position – Neuroscience (Children’s Hospital, Harvard Medical School)

Postdoctoral Position – Molecular Pharmacology (Albert Einstein College of Medicine)

Postdoctoral Fellow – Stem Cell Biology (Johns Hopkins School of Medicine)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Neural Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Neural Cell News: Archives | Events | Contact Us